Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Engelmann

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Methods in Molecular Medicine|April 6, 2004
Purification of TNF binding proteinsHartmut Engelmann, Dani Aderka, David Wallach
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2005
TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRsJulia Hauer, Stephanie Püschner, Parameswaran Ramakrishnan, et al.
Leukemia Research|June 28, 2005
Functional T-cell anergy in a case of persistent polyclonal B-cell lymphocytosisManfred Mitterer, Andrea J Lanthaler, Eveline U Irschick, et al.
Journal of Neuroimmunology|April 19, 2005
Death receptor-mediated apoptosis in human malignant glioma cells: modulation by the CD40/CD40L systemJörg Wischhusen, Dagmar Schneider, Michel Mittelbronn, et al.
The Journal of Biological Chemistry|September 25, 2003
Two distinct transport motifs in the adenovirus E3/10.4-14.5 proteins act in concert to down-modulate apoptosis receptors and the epidermal growth factor receptorAnnette Hilgendorf, Johan Lindberg, Zsolt Ruzsics, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Methods in Molecular Medicine|April 6, 2004
Purification of TNF binding proteinsHartmut Engelmann, Dani Aderka, David Wallach
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2005
TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRsJulia Hauer, Stephanie Püschner, Parameswaran Ramakrishnan, et al.
Leukemia Research|June 28, 2005
Functional T-cell anergy in a case of persistent polyclonal B-cell lymphocytosisManfred Mitterer, Andrea J Lanthaler, Eveline U Irschick, et al.
Journal of Neuroimmunology|April 19, 2005
Death receptor-mediated apoptosis in human malignant glioma cells: modulation by the CD40/CD40L systemJörg Wischhusen, Dagmar Schneider, Michel Mittelbronn, et al.
The Journal of Biological Chemistry|September 25, 2003
Two distinct transport motifs in the adenovirus E3/10.4-14.5 proteins act in concert to down-modulate apoptosis receptors and the epidermal growth factor receptorAnnette Hilgendorf, Johan Lindberg, Zsolt Ruzsics, et al.
Pageof 1